Myriad Genetics Delivers Gender Reveal Happiness to Over a Million Expectant Parents, Reports 22.7% Revenue Growth
In an era where genetic testing and precision medicine have revolutionized healthcare, Myriad Genetics, Inc. (NASDAQ: MYGN) stands out as a leader in the field. The company recently celebrated a significant milestone, a...
Nov 20, 2023
Product Service News